Genprex, Inc.

US$2.07As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GNPXHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (73.75%)
Div yield —
ROE (203.86%)
Biotechnology
Beta (5Y) (0.99)
PE TTM —
TSR TTM (98.37%)
Mkt cap US$1.697M
ROIC (122.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.48
20.03%
(40.05%)
Hold 0|2|7|9|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
7.59%
3.26%
6.34%
9.19%
Revenue$M
0.142
0.139
0.146
0.151
6.10%
4.39%
5.99%
3.32%
Peers (US$1.697M)
Cap (US$)
PE
1.936M
—
1.575M
—
Capital
TTM
5Y
10Y
Leveragex
0.862
—
—
EBIT/Intx
1.171
1.479
1.716
Own earn%
76.78
(16.22)
(16.27)
Sh yield%
25.92
46.57
46.98
Owners
Insiders/Inst%
13.50
42.36
Short interest%
3.46
SBC / revenue%
4.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
23–27
$1 testx
0.0
Incr. ROIC%
2